The X-ray features of breast ductal carcinoma in situ and its small invasive foci and correlation between mammographic features and prognostic biologic factors

Chinese Journal of Radiology

Volumn 41, Issue 6, 2007, Pages 623-628

  Gu, Ya Jia ^a   Xiao, Qin ^b   Yang, Wen Tai ^b   Zheng, Xiao Jing ^b   Gu, Rong Feng ^b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b NONE

Author keywords

Breast neoplasms; Carcinoma; Intraductal; Mammography; Noninfiltrating

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CALCIFICATION; CANCER INVASION; CARCINOMA IN SITU; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMAGE ANALYSIS; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT PLANNING;

EID: 34447304856     PISSN: 10051201     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst, 2002,94:1546-1554.
2. Ernster VL, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr, 1997,22:151-156.
3. Feig SA. Ductal carcinoma in situ: implications for screening mammography. Radilo Clin North Am, 2000,38:653-668.
4. Karamouzis MV, Likaki-Karatza E, Ravazoula P, et al. Nonpalpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer, 2002, 102:86-90.
5. American College of Radiology (ACR). Breast imaning reporting and data system (BI-RADS). 4th ed Reston: Am College Radiol, 2003:1-259.
6. Chinese source.
7. Chinese source.
8. Barreau B, de Mascarel I, Feuga C, et al. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol, 2005, 54: 55-61.
9. Chinese source.
10. Franceschi D, Crowe JP, Lie S, et al. Not all nonpalpable breast cancers are alike. Arch Surg, 1991, 126:967-970.
11. Hermann G, Janus C, Schwartz IS, et al. Occult malignant breast lesions in 114 patients: relationship to age and the presence of microcalcifications. Radiology, 1988,169:321-324.
12. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet, 1995, 345:1154-1157.
13. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer, 1996, 77: 2267-2274.
14. Cornfield DB, Palazzo JP, Schwartz GF, et al. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cancer, 2004, 100: 2317-2327.
15. Zafrani B, Leroyer A, Fourqurt A, et al. Mammographically-detected ductal in situ carcinoma of the breast analysed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol, 1994, 11:208-214.
16. Yang M, Moriya T, Oguma M, et al. Microinvasive ductal carcinoma (T1 mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases. Pathology International, 2003, 53: 422-428.